Deepson Bio
PrivateLast Round
Pre A
Apr 14, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Deepson Bio is a medical technology company that develops therapeutic ultrasound devices intended to treat severe diseases and disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Deepson Bio Comparables
Compare Deepson Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neurosona | 86% | |
| Ceretas | 84% | |
| Zhongke Green Valley (Shenzhen) Medical Technology Co., Ltd. | 83% |
Deepson Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre A | Apr 14, 2025 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 13, 2026
Open job postings increased to 1 role, representing 33% of headcount.
- Jun 21, 2026
Monthly visitors increased 60% MoM.
Deepson Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Deepson Bio's valuation, stock price, and market status.
Is Deepson Bio a public or private company?
Deepson Bio is a private company.
What is the current stock price of Deepson Bio?
Deepson Bio is a private company, so its shares have no public market price. Caplight tracks Deepson Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Deepson Bio worth (valuation)?
Valuation information for Deepson Bio is not publicly available.
Can I buy Deepson Bio stock?
Deepson Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Deepson Bio's last funding round?
Deepson Bio's most recent funding round was Pre A on April 14, 2025.
Who are the main investors in Deepson Bio?
Investor information for Deepson Bio is not publicly disclosed.
Will Deepson Bio IPO soon?
No public IPO plans have been announced for Deepson Bio.
How can I track Deepson Bio secondary market activity?
Caplight tracks bids, offers, and trades in Deepson Bio's shares on secondary markets.